持田製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2014/02/20 | 6,570 | 6,750 | 6,550 | 6,620 | +60 | +0.9% | 77,400 |
2014/02/19 | 6,520 | 6,570 | 6,470 | 6,560 | -10 | -0.2% | 28,600 |
2014/02/18 | 6,440 | 6,590 | 6,430 | 6,570 | +190 | +3% | 54,500 |
2014/02/17 | 6,230 | 6,390 | 5,980 | 6,380 | -150 | -2.3% | 90,700 |
2014/02/14 | 6,490 | 6,600 | 6,360 | 6,530 | +80 | +1.2% | 72,700 |
2014/02/13 | 6,490 | 6,640 | 6,380 | 6,450 | ±0 | ±0% | 58,400 |
2014/02/12 | 6,140 | 6,490 | 6,140 | 6,450 | +410 | +6.8% | 68,800 |
2014/02/10 | 6,050 | 6,060 | 5,950 | 6,040 | +40 | +0.7% | 25,800 |
2014/02/07 | 5,960 | 6,010 | 5,870 | 6,000 | +90 | +1.5% | 32,300 |
2014/02/06 | 6,190 | 6,190 | 5,870 | 5,910 | -330 | -5.3% | 60,600 |
2014/02/05 | 6,300 | 6,370 | 6,110 | 6,240 | +440 | +7.6% | 80,100 |
2014/02/04 | 5,910 | 5,940 | 5,800 | 5,800 | -210 | -3.5% | 47,400 |
2014/02/03 | 6,050 | 6,090 | 5,990 | 6,010 | +60 | +1% | 24,700 |
2014/01/31 | 6,020 | 6,070 | 5,850 | 5,950 | -60 | -1% | 33,300 |
2014/01/30 | 6,050 | 6,170 | 5,980 | 6,010 | -210 | -3.4% | 23,800 |
2014/01/29 | 6,080 | 6,220 | 6,080 | 6,220 | +150 | +2.5% | 12,900 |
2014/01/28 | 6,180 | 6,240 | 6,060 | 6,070 | -110 | -1.8% | 43,400 |
2014/01/27 | 6,240 | 6,260 | 6,150 | 6,180 | -90 | -1.4% | 39,600 |
2014/01/24 | 6,280 | 6,360 | 6,200 | 6,270 | -110 | -1.7% | 35,500 |
2014/01/23 | 6,480 | 6,480 | 6,360 | 6,380 | -110 | -1.7% | 28,900 |
2014/01/22 | 6,470 | 6,500 | 6,410 | 6,490 | +30 | +0.5% | 18,600 |
2014/01/21 | 6,450 | 6,470 | 6,400 | 6,460 | +20 | +0.3% | 20,500 |
2014/01/20 | 6,380 | 6,470 | 6,360 | 6,440 | +70 | +1.1% | 22,200 |
2014/01/17 | 6,300 | 6,390 | 6,250 | 6,370 | +40 | +0.6% | 29,700 |
2014/01/16 | 6,290 | 6,370 | 6,240 | 6,330 | +70 | +1.1% | 34,300 |
2014/01/15 | 6,220 | 6,270 | 6,170 | 6,260 | +60 | +1% | 25,800 |
2014/01/14 | 6,230 | 6,230 | 6,120 | 6,200 | +10 | +0.2% | 36,900 |
2014/01/10 | 6,210 | 6,210 | 6,110 | 6,190 | +10 | +0.2% | 45,600 |
2014/01/09 | 6,180 | 6,190 | 6,120 | 6,180 | -10 | -0.2% | 39,600 |
2014/01/08 | 6,190 | 6,190 | 6,110 | 6,190 | +20 | +0.3% | 22,900 |
2014/01/07 | 6,120 | 6,190 | 6,120 | 6,170 | ±0 | ±0% | 25,500 |
2014/01/06 | 6,250 | 6,250 | 6,110 | 6,170 | -80 | -1.3% | 40,100 |
2013/12/30 | 6,200 | 6,320 | 6,180 | 6,250 | +150 | +2.5% | 49,500 |
2013/12/27 | 6,020 | 6,100 | 5,940 | 6,100 | +140 | +2.3% | 37,000 |
2013/12/26 | 5,770 | 5,970 | 5,770 | 5,960 | +250 | +4.4% | 25,100 |
2013/12/25 | 5,750 | 5,750 | 5,690 | 5,710 | -60 | -1% | 31,600 |
2013/12/24 | 5,840 | 5,870 | 5,770 | 5,770 | -110 | -1.9% | 20,400 |
2013/12/20 | 5,920 | 5,920 | 5,850 | 5,880 | -90 | -1.5% | 36,500 |
2013/12/19 | 5,890 | 5,970 | 5,890 | 5,970 | +80 | +1.4% | 58,700 |
2013/12/18 | 5,890 | 5,940 | 5,850 | 5,890 | -50 | -0.8% | 50,400 |
2013/12/17 | 5,800 | 5,940 | 5,800 | 5,940 | +160 | +2.8% | 52,700 |
2013/12/16 | 5,940 | 5,960 | 5,780 | 5,780 | -60 | -1% | 49,500 |
2013/12/13 | 5,910 | 5,910 | 5,810 | 5,840 | -110 | -1.8% | 97,800 |
2013/12/12 | 6,000 | 6,000 | 5,940 | 5,950 | -60 | -1% | 38,600 |
2013/12/11 | 6,050 | 6,050 | 5,980 | 6,010 | -20 | -0.3% | 43,100 |
2013/12/10 | 6,090 | 6,090 | 6,020 | 6,030 | -50 | -0.8% | 31,300 |
2013/12/09 | 6,080 | 6,090 | 6,030 | 6,080 | +70 | +1.2% | 27,500 |
2013/12/06 | 6,010 | 6,030 | 5,940 | 6,010 | ±0 | ±0% | 44,500 |
2013/12/05 | 6,030 | 6,060 | 6,010 | 6,010 | -50 | -0.8% | 30,900 |
2013/12/04 | 6,080 | 6,140 | 6,020 | 6,060 | -30 | -0.5% | 49,000 |
2751~
2800
件表示中 / 3705件
類似銘柄と比較する
現在ご覧いただいている「持田薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
持田薬 | 297,600円 | +5.1% | -7.0% | 2.69% | 19.54倍 | 0.81倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
ジーエヌアイ | 297,100円 | +21.7% | +999.9% | 0.00% | 12.45倍 | 4.12倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
ゼリア新薬 | 213,700円 | +3.1% | -6.5% | 2.25% | 9.92倍 | 1.05倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
杏林製薬 | 146,000円 | -2.4% | -52.3% | 3.90% | 17.47倍 | 0.62倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
栄研化 | 200,000円 | +4.1% | -3.1% | 2.90% | 17.54倍 | 1.53倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
市場注目の銘柄
チャート関連のコラム